Pharmadrug Stock Market Value
| LMLLF Stock | USD 0.01 0.0005 7.25% |
| Symbol | Pharmadrug |
Pharmadrug 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Pharmadrug's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Pharmadrug.
| 12/01/2025 |
| 03/01/2026 |
If you would invest 0.00 in Pharmadrug on December 1, 2025 and sell it all today you would earn a total of 0.00 from holding Pharmadrug or generate 0.0% return on investment in Pharmadrug over 90 days. Pharmadrug Inc. operates as a specialty pharmaceutical company More
Pharmadrug Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Pharmadrug's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Pharmadrug upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 26.1 | |||
| Information Ratio | 0.0489 | |||
| Maximum Drawdown | 86.01 | |||
| Value At Risk | (30.84) | |||
| Potential Upside | 29.73 |
Pharmadrug Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Pharmadrug's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Pharmadrug's standard deviation. In reality, there are many statistical measures that can use Pharmadrug historical prices to predict the future Pharmadrug's volatility.| Risk Adjusted Performance | 0.051 | |||
| Jensen Alpha | 0.7867 | |||
| Total Risk Alpha | (0.87) | |||
| Sortino Ratio | 0.0319 | |||
| Treynor Ratio | 0.5753 |
Pharmadrug March 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.051 | |||
| Market Risk Adjusted Performance | 0.5853 | |||
| Mean Deviation | 10.71 | |||
| Semi Deviation | 14.15 | |||
| Downside Deviation | 26.1 | |||
| Coefficient Of Variation | 1846.45 | |||
| Standard Deviation | 17.05 | |||
| Variance | 290.79 | |||
| Information Ratio | 0.0489 | |||
| Jensen Alpha | 0.7867 | |||
| Total Risk Alpha | (0.87) | |||
| Sortino Ratio | 0.0319 | |||
| Treynor Ratio | 0.5753 | |||
| Maximum Drawdown | 86.01 | |||
| Value At Risk | (30.84) | |||
| Potential Upside | 29.73 | |||
| Downside Variance | 681.34 | |||
| Semi Variance | 200.36 | |||
| Expected Short fall | (17.76) | |||
| Skewness | (0.04) | |||
| Kurtosis | 1.45 |
Pharmadrug Backtested Returns
Pharmadrug appears to be out of control, given 3 months investment horizon. Pharmadrug maintains Sharpe Ratio (i.e., Efficiency) of 0.0436, which implies the firm had a 0.0436 % return per unit of risk over the last 3 months. By analyzing Pharmadrug's technical indicators, you can evaluate if the expected return of 0.77% is justified by implied risk. Please evaluate Pharmadrug's Risk Adjusted Performance of 0.051, coefficient of variation of 1846.45, and Semi Deviation of 14.15 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Pharmadrug holds a performance score of 3. The company holds a Beta of 1.59, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Pharmadrug will likely underperform. Please check Pharmadrug's potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to make a quick decision on whether Pharmadrug's historical price patterns will revert.
Auto-correlation | -0.04 |
Very weak reverse predictability
Pharmadrug has very weak reverse predictability. Overlapping area represents the amount of predictability between Pharmadrug time series from 1st of December 2025 to 15th of January 2026 and 15th of January 2026 to 1st of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Pharmadrug price movement. The serial correlation of -0.04 indicates that only as little as 4.0% of current Pharmadrug price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.04 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Other Information on Investing in Pharmadrug Pink Sheet
Pharmadrug financial ratios help investors to determine whether Pharmadrug Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmadrug with respect to the benefits of owning Pharmadrug security.